FDA-Drug2019-07-17Class II
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
American Health Packaging
Hazard
GMP Deviations: Potential cross contamination due to cleaning procedure failure.
Sold states
Nationwide USA
Affected count
375,921 bottles
Manufactured in
2550 John Glenn Ave Ste A, Columbus, OH, United States
Products
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1467-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief